SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is facing intense selling pressure and significant community debate as its leveraged position in Bitcoin and complex dividend structure trigger concerns about a potential death spiral. Investors are actively split between those who view the current price drop as a generational buying opportunity and critics who fear forced liquidations and dilution will drive the stock toward bankruptcy.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors react to a recent SEC filing regarding executive change-of-control agreements, which is fueling speculation of an imminent acquisition. The community is actively discussing an expected clinical trial readout and significant short-squeeze pressure, as the stock faces high borrow fees and trapped short positions.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors weigh recent volatility against upcoming catalysts, specifically the anticipated European Medicines Agency regulatory decision and the July 1 J-code implementation for Yartemlea. The community is actively debating the significance of recent leadership departures and sales data, with many shareholders dismissing current price swings as manipulative short-term tactics while maintaining a long-term outlook on the drug's commercial adoption.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing significant downward pressure and intense community scrutiny as investors react to a leadership transition and ongoing skepticism regarding the company's turnaround timeline before upcoming earnings. While some see a value opportunity in the brand's long-term global presence, many traders are vocal about the persistent downtrend and competitive challenges from emerging athletic brands.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors react to new government executive orders and federal initiatives that fast-track quantum computing, positioning the company as a key player in national security. The community is actively discussing the stock's role in government-backed projects, the impact of its upcoming Russell index inclusion, and high-conviction options activity while speculating on the company's long-term growth potential.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is facing a massive sell-off as retail investors express deep frustration over persistent share dilution and the stock's failure to track its underlying Ethereum holdings. Community discourse is highly polarized, with many calling for investigations into management's strategy while bargain-hunters debate whether the current price represents a capitulation bottom or the start of a terminal decline.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is drawing significant investor interest and market volatility following the announcement of a $7 billion all-stock deal to acquire Synaptics, a move aiming to bolster the company's position in Physical AI and edge computing. While analysts are divided on the strategic value of the acquisitionwith some highlighting long-term synergy potential in sensing and connectivity and others raising concerns about deal complexitythe community is actively debating the integration risks versus the potential to become a dominant force in AI-enabled hardware.

TOYO Co. Ltd. engages in the design, manufacture, and sale of solar cells and modules. It is involved in integrating the upstream production of wafer and silicon, midstream production of solar cell, downstream production of photovoltaic (PV) modules, and potentially other stages of the solar power supply chain. The company was founded on November 8, 2022 and is headquartered in Tokyo, Japan.

TOYO Co Ltd.

TOYO Co., Ltd

Toyo Co., Ltd. is attracting significant investor attention as the market re-evaluates its rapid expansion into U.S. solar manufacturing alongside its established Ethiopian production capacity. The community remains bullish, citing a compelling valuation, strong institutional buying, and the strategic resolution of past legal hurdles as key catalysts for a potential multi-year growth trajectory.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is experiencing heightened volatility as investors weigh the impact of shifting interest rate expectations against sector-wide enthusiasm for recent clinical breakthroughs and potential M&A activity. The community remains focused on identifying derisked assets with strong balance sheets to navigate broader market pressures while keeping a close eye on upcoming regulatory readouts.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense selling pressure as investors grapple with concerns over the company's heavy AI infrastructure spending and its exposure to OpenAI, fueling community debate about potential market manipulation versus fundamental value. While some retail investors remain cautious, many are highlighting the company's record backlog as a bullish catalyst for a long-term recovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cocrystal Pharma Names James Sapirstein CEO, Stock Up In Pre-market

(RTTNews) - Cocrystal Pharma, Inc. (COCP) on Wednesday announced that it has appointed James Sapirstein chief executive officer, effective immediately, replacing co-chief executives Sam Lee and Jim Martin...

Why Cocrystal Pharma Shares Are Cooling Off Monday?

COCP stock is trading lower Monday morning. Learn why Cocrystal Pharma is seeing a pullback after receiving FDA Fast Track designation for CDI-988.read more...

Top Biotech Stocks To Follow Today - April 4th

Vertex Pharmaceuticals, Danaher, United Therapeutics, argenex, Moderna, Cocrystal Pharma, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results

US stocks fall, Dow drops over 50 points, real estate shares rise, Acuity Inc. shares decline, Sky Quarry Inc. and Cocrystal Pharma Inc. shares increase.read more...

Energy Crunch Sparks Sector Rally and Hidden Players Stepping into the Spotlight

A powerful convergence of global energy disruption and emerging technology catalysts is reshaping pockets of the market, with select small-cap names ready to make moves. $SKYQ, $XERI, $KBLB, $TGNT, $BDRX, $COCP

Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988

Cocrystal Pharma Inc. (NASDAQ:COCP) shares are trading higher Thursday after it received Fast Track designation from the FDA for its CDI-988.read more...

COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment?

Equity

Cocrystal stated that the Fast Track designation for CDI-988 enables accelerated development and expedited regulatory review.

Cocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost Acquires 50,000 Shares

Cocrystal Pharma, Inc. (NASDAQ:COCP - Get Free Report) Director Phillip Md Et Al Frost purchased 50,000 shares of Cocrystal Pharma stock in a transaction that occurred on Friday, February 6th. The...

Phillip Md Et Al Frost Acquires 50,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock

Cocrystal Pharma, Inc. (NASDAQ:COCP - Get Free Report) Director Phillip Md Et Al Frost bought 50,000 shares of the company's stock in a transaction on Wednesday, December 31st. The shares were...

Cocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost Buys 20,000 Shares

Cocrystal Pharma, Inc. (NASDAQ:COCP - Get Free Report) Director Phillip Md Et Al Frost bought 20,000 shares of the firm's stock in a transaction dated Tuesday, December 30th. The stock was acquired...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs. The company was founded in 2008 and is headquartered in Bothell, WA.

Cocrystal Pharma Inc

Bullish Sentiment

$UBER only

$INTC only

Both $UBER and $INTC

Neither

Nancy Pelosi recently disclosed trades in both Uber ($UBER) and Intel ($INTC) - are you following her into either? Cast your vote below.

Are you following Nancy Pelosi into her latest trades - Uber ($UBER) and Intel ($INTC)?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.17	--	--	N/A
Q1 '26	-$0.15	-$0.17	-13.33%	MISSED
Q4 '25	-$0.17	-$0.16	8.57%	BEAT
Q3 '25	-$0.22	-$0.19	11.63%	BEAT
Q2 '25	-$0.23	-$0.20	13.04%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

COCPCocrystal Pharma Inc

Latest Earnings Results: Q1 '26

Historical Earnings

Latest COCP News